Italian Laboratory Expands ProtoKinetix' Market for AAGP(TM) MarketWatch (press release) This significant increase in yield, will result in major cost reductions for the treatment of cardio vascular disease, auto-immune disorders, leukemia, transplant rejection, cancer as well as numerous diagnostics. ProtoKinetix, Inc. is a biotechnology ... |
